Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 6.860

-6.3%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tom pope	5/25/2009 10:52:58 AM
	of 269

Shionogi Gains as Prepares to Seek Flu Drug Approval (Update1) By Eijiro Ueno May 25 (Bloomberg) -- Shionogi & Co. rose to the highest in four months after the Nikkei newspaper reported the company aims to sell a new drug for influenza as early as 2010. Shionogi shares jumped 5.7 percent to 1952 yen on the Tokyo Stock Exchange, its highest close since Jan. 9. The Nikkei 225 Stock average was 1.3 percent higher at 9,347.00 at the close. The Osaka-based pharmaceutical company is currently analyzing phase 3 test data for the drug Peramivir, said spokesman Yoshimasa Kyokawa, confirming the Nikkei report. “We are preparing to submit an application for this as a new drug, as if we can make the application by this autumn, we could have approval as early as autumn 2010,” Kyokawa said by phone today.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next